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Abstract.  The role of prostanoids in the regulation of 
chick myoblast differentiation has been investigated.  At 
3  x  10  -6 M,  indomethacin and chloroquine specifi- 
cally inhibit cell fusion. They do not affect cell 
proliferation,  alignment,  or the expression of two 
muscle-specific proteins,  namely, the acetylcholine 
receptor and the muscle-specific form of creatine 
phosphokinase.  The results demonstrate that it is in- 
domethacin's activity as an inhibitor of prostaglandin 
synthesis at the cyclyooxygenase step that causes the 
block of cell fusion, whereas chloroquine probably 
acts at the earlier step of phospholipase A. Prostaglan- 
din Et (PGE0, but not prostaglandin  E2 (PGE2), rap- 
idly reverses the inhibition of fusion imposed by indo- 
methacin or chloroquine.  The dose response of the 
myoblasts to PGE~ is a bell-shaped curve with a  100% 
reversal of fusion at ,~10  -9 M.  Eicosatrienoate and 
linoleate reverse the inhibition of fusion with similar 
kinetics,  whereas aracl~idonate  is completely ineffec- 
tive. The ability of PGE~ and eicosatrienoate but not 
PGF~ and arachidonate to restore fusion to control lev- 
els implies that fusion is specifically regulated by a 
prostanoid of the one series.  The reversal of the 
fusion-block by linoleate further suggests that this fatty 
acid provides the necessary source of eicosatrienoate 
in the myoblast plasma membrane.  At 10  -8 M  and 
above, PGE~ and PGE2 stimulate adenylate cyclase and 
depress control fusion as does 10  -5 M  isoproterenol. 
The I]-adrenergic blocker propranolol abolishes both 
isoproterenol's inhibition of myoblast fusion and its ac- 
tivation of adenylate cyclase. The similar depressions 
imposed on cell fusion by 10-g-10  -~ M  prostanoid and 
10  -5 M  isoproterenol suggest that in both cases the 
depressive effects are mediated by cyclic AMP. It is 
concluded that a prostanoid of the one series regulates 
fusion by a cyclic AMP-independent mechanism. 
T 
HE multinucleated  skeletal muscle fiber is formed by 
the  fusion  of mononucleated  precursor  myoblasts. 
Both in vivo and in culture,  the bipolar myoblasts ini- 
tially undergo a phase of proliferation  while aligning  along 
their longitudinal axes. Membrane fusion subsequently takes 
place between the aligned cells. At approximately  the same 
time as the onset of cell-cell fusion, the embryonic muscle 
cell ceases DNA synthesis and cell division and initiates the 
elaboration of the specialized proteins associated with skele- 
tal muscle contraction.  The relationship  between these three 
events is not yet fully elucidated.  However, it is accepted that 
the expression of muscle-specific proteins can be uncoupled 
from the fusion event and that once inside a multinucleate 
cell, the myogenic nuclei are incapable  of either DNA syn- 
thesis or cell division. 
Numerous agents have been identified that inhibit cell-cell 
fusion (41). Most of these inhibitions  probably represent a 
more general block of differentiation or cellular function.  An 
exception to this is the inhibition  of cell fusion achieved by 
lowering external calcium.  Unfortunately,  reducing external 
Ca  ++ to investigate the mechanism  of myoblast fusion is of 
limited use. First, the effects of this manipulation  are not al- 
ways limited to myoblast fusion.  The expression of muscle- 
specific proteins can also be inhibited  (5, 30, 39). Second, 
inhibiting fusion by limiting the availability of calcium is not 
an appropriate manipulation  for investigation of events that 
occur before the calcium-dependent step.  These two con- 
siderations  led us to study other methods of achieving  spe- 
cific and reversible  inhibitions  of the fusion event itself. 
Prostanoids  (products  of the cyclooxygenase pathway in- 
cluding thromboxanes,  the prostaglandins,  and their metabo- 
lites) are implicated in the regulation of myoblast differentia- 
tion. Low concentrations  of putative inhibitors of prostanoid 
synthesis  prevent  the onset of the fusion process (44) and 
this  is reversible by exogenously  added prostaglandin  E~, 
(PGEI) 1 (11, 44). However, neither of these inhibitor  studies 
examined  the effects of manipulating  prostanoid levels  on 
other aspects of differentiation  and so the degree of speci- 
ficity of the effects of PGE on cell fusion is therefore not 
known. 
In this study, we present the results of an investigation into 
the nature  of the inhibitions  imposed upon myoblast fusion 
by low concentrations  of putative  inhibitors  of prostanoid 
synthesis.  Specifically,  the effects of indomethacin  (an  in- 
hibitor of cyclooxygenase) and chloroquine (an inhibitor  of 
L  Abbreviations  used in this  paper:  PGE~ and PGE2, prostaglandins El 
and E2, respectively. 
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liferation, and the expression of acetylcholine receptors and 
muscle-specific creatine  phosphokinase  have  been  exam- 
ined. Data are presented that assess prostanoid synthesis as 
the critical site of action of the drugs in their block of myo- 
blast fusion. This mechanism of blocking myoblast fusion is 
then employed to investigate the capacity of endogenously 
produced prostanoid to trigger cell fusion. Finally, the role 
of cyclic AMP in the regulation of  myoblast fusion is reexam- 
ined. 
Materials and Methods 
Cell Cultures 
Chick myoblast cultures were prepared from Stage 39 chicks (18). The legs 
were dissected free of skin, bones, and other noamuscle tissue. The har- 
vested tissue was then finely scissored in complete medium and agitated by 
vortex mixing (37). A suspension of single cells was prepared by filtering 
the resultant tissue preparation through two layers of nylon mesh (pore size 
30 Ixm) and repeatedly pipetted immediately before use. Cells were plated 
out  in  1.2  rod of medium at  a  density of 1.4  ×  l0  s cells per 35-mm 
collagen-coated petri dish (Falcon Labware,  Oxnard,  CA).  The culture 
medium contained Medium 199 (Gibco, Grand Island, NY) supplemented 
with 10% horse serum (Flow Laboratories, Flow General Inc., McLean, 
VA), 2 % embryo extract,  100 U/mi of penicillin, and 100 U/ml of strep- 
tomycin (Gibco), and was adjusted to a final pH of 7.4. The cells were cul- 
tured at 37"C in 5% CO: at 100% humidity. A complete medium change 
was carried out 24 h after the initial plating. 
Drug Additions 
Chloroquine,  mepacrine,  and  indomethacin  (Sigma  Chemical  Co.,  St. 
Louis, MO) were routinely added as 30 ~tl of concemrate made up in Earle's 
salts (Gibco), at ,'~12-h intervals, commencing after the medium change. 
Controls were dosed with 30 ~tl of Earie's salts at each addition. The drugs 
were made up immediately before use. Linoleic acid (9,12 octadecadienoic 
acid; Sigma Chemical Co.), eicosatrienoic acid (8,11,14 eicosatrienoic acid; 
Sigma Chemical Co.), and arachidonic acid (5,8,11,14 eicosatetraanoic acid; 
Koch-Light Laboratories,  Colnbrook,  Buckinghamshire,  England)  were 
stored as 10  -2 M ethanolic stock solutions at  -40°C. Immediately before 
use, the stock solutions were titrated ,with ethanolic sodium hydroxide and 
diluted with acidic Earle's salts (pH 4). 30 ~tl of the appropriate concentrate 
was added to the dishes at 48 h in culture. PGE~ and PGE2 (Sigma Chemi- 
cal Co.) were stored as 10  -3 M ethanolic stock solutions. Immediately be- 
fore use, these were diluted with Earle's salts and administered to the dishes 
in a similar manner to the essential fatty acid esters. Isoproterenol, propran- 
oloi, and dibutyryl cyclic AMP (Sigma Chemical Co.) were prepared in 
Earle's salts on the day of use. Isoproterenul and dibutyryl cyclic AMP were 
added at 48 h  of culture and, when appropriate, propranolol was added 
30 rain before this. 
Cell Counts 
All  counts  were performed on  an  Olympus  inverted microscope at  a 
magnification of 200.  Cell numbers were estimated by direct microscopic 
examination of either living cultures under phase-contrast optics or fixed 
and stained cultures (see below) with bright field optics. In prefusion cul- 
tures,  the  numbers  of cells  counted  by  the  two  techniques  were  not 
significantly ditferent (data not presented). 
A cell was defined as aligned if it had a bipolar morphology, its longitudi- 
nal axis parallel to the longitudinal axes of at least two neighboring cells, 
and was in contact with at least one of them. Dividing cells were included 
in the tally of unaligned cells and the counts were performed using phase- 
contrast optics. 
Cell fusion was estimated by microscopic examination of glutaraldehyde- 
fixed and Giemsa-stainnd cultures, employing bright field optics. Percentage 
fusion was calculated by counting the number of nuclei in multinucleated 
cells, dividing this by the total number of nuclei observed, and multiplying 
by 100. 
To facilitate the comparison of results obtained in separate experiments, 
results were routinely plotted as a fusion index. The fusion index is the per- 
centage fusion in the treated cultures divided by the percentage fusion in 
control cultures. All values presented represent the mean +  SD. Where no 
SD is apparent, it is contained within the point itself. 
Adenosine 3':5'-Cyclic Monophosphate Assay 
Cyclic AMP was assayed as described previously (10). Hormone incuba- 
tions were terminated by rapid aspiration of the bathing medium and the ad- 
dition of 2 ml of ice-cold 5 % TCA.  1 ml of the supernatant achieved after 
centrifugation was then applied to a Dowex-50 column (0.5  x  8 cm; Dow 
Chemical Co., Midland, MI) and ehted with 0.05 M HCI. The eluate was 
collected, and its cyclic AMP content assessed using a competitive binding 
assay (4). Using the above procedure a minimum of 90% of the total cyclic 
AMP was detected. 
DNA Assay 
The DNA content oftbe cultures was measured as described by Kissane and 
Robins (24). The dishes were rapidly rinsed twice at room temperature with 
physiological saline and the cells removed with a silicone rubber stopper. 
The samples were then ultrasonicated and quadruplicate 50-gl aliquots were 
transferred to tubes that were previously rinsed with double-glass distilled 
water. These were evaporated to dryness and incubated at 60°C for 45 rain 
with 50  gl  of 3,5-diaminobenzoic acid.  The reaction was stopped with 
2.5 ml of I M HC1.0.5-4.0 gg of calf thymus DNA (Sigma Chemical Co.) 
was used to produce a standard curve. 
Creatine Phosphokinase Assay 
The cells were stored at -80"C until required for analysis. The plates were 
then rapidly thawed and the cells scraped off the dishes into cold 100 mM 
Tris-HCl (pH 6.8) with 5 mM magnesium acetate (BDH Chemicals, Poole, 
England).  The resulting suspension was ultrasonicated and the creatine 
phosphokinase levels assayed (8, 26). A standard curve was constructed for 
creatine over a concentration range of 100--400 nM and subjected to the 
same conditions of incubation and analysis. 
Visualization of  the Muscle-specific Form of  Creatine 
Phosphokinase Using lmmunofluorescent  Staining 
The cells were fixed in -20"C acetone/methanol (1:1) for 1.5 rain and stored 
at 4°C. Before the first antibody addition, each dish was preincubated for 
30 min at 37"C with 1 mi of PBS containing 10% horse serum. The samples 
were then rinsed and incubated for 1 h at 370C in >95% humidity with (a) 
anti-muscle-specific creatine phosphokinase at a dilution of 1/100 (gener- 
ously donated by J. C. Perriard, Institute for Cell Biology, Swiss Federal 
Institute of Technology, Ziirich, Switzerland), and (b) anti-rabbit FITC- 
conjugated immunoglobulin O (Sigma Chemical Co.) at a dilution of 1/40. 
Finally, each dish was thoroughly rinsed with PBS (pH 7.4).  The cells were 
counted (x300) on a Zeiss III RS microscope with epifluorescence. Each 
nucleus was identified using phase optics and the cytoplasm immediately 
around the nucleus scored for positive staining with fluorescein. A tally was 
maintained of the total number of cells and those that stained for muscle- 
specific creatine phosphokinase. Percentage staining was calculated as the 
number of nuclei with fluorescence in their surrounding cytoplasm, divided 
by the total number of nuclei observed, and multiplied by 100. As this proce- 
dure involves a subjective element, the dishes were counted blind. 
Assessment of  DNA and Protein Synthesis 
0.5  I~Ci per  35-ram  dish  of  [3H]thymidine  (Amersham  International, 
Amersham, Buckinghamshire, England), made up to  10  -6 M  with unla- 
beled thymidine, or 0.5  }~Ci per 35-mm dish of carrier-fre~ [3H]leucine 
(specific activity 60 Ci mM  -1) (Amersham International) were added to 
the dishes 6 h before harvesting. The cells were then rinsed rapidly three 
times with physiological saline at room temperature and removed with a sili- 
cone rubber stopper in  1 ml of physiological saline containing 1%  BSA 
(Sigma Chemical Co.). 1 ml of 10% TCA (Sigma Chemical Co.) was added 
and the sample left overnight at 4°C. The resulting precipitate was centri- 
fuged at 900 g  for 5 min, the supernatant discarded, and the pellet resus- 
pended in 2 ml of 5 % "ICA. This rinsing procedure was repeated twice. The 
final precipitate was dissolved in a scintillation cocktail (NE260;  Nuclear 
Enterprises Limited, Edinburgh, Scotland) and counted in a liquid scintilla- 
tion counter (model L5 7500;  Beckman Instruments Inc., Fullerton, CA). 
The Journal  of Cell Biology, Volume 103, 1986  858 Percent fusion 
1o0.  )¢ 
z 
z 
0.8. 
(Cell Nos./cm  2 dish)  x  10  -3 
Control  Chloroquine  Indomethacin  Control  Chloroquine  Indomethacin 
43.6  +  1.6  16.3  +  1.2  20.7  +  1.2  34.9  +  1.9  36.0  5-  3.5  38.7  5- 4.8 
43.9  +  1.1  16.2  +  1.2  21.6  5-  1.0  37.7  5- 2.6  35.9  -I- 3.9  37.6  5- 2.5 
45.0  +  1.7  14.5  +  1.8  20.7  5-  1.1  42.7  -I- 2.9  41.8  5-  3.7  40.3  5-  5.5 
42.2  5-  3.4  14.7  +  2.4  18.3  +  2.0  50.9  +  5.6  52.3  5- 9.7  52.3  +  4.8 
The data were collected from 58-h cultures. All values represent the mean of four dishes +  the SD. 
Acetylcholine Receptor Assay 
Acetylcholine  receptors  were  assayed  as  described  previously  (27).  4 
nCi/35-mm dish of [t2sI]abungarotoxin (generous gift of S. Bevan, Depart- 
ment of Zoology, University College London, London), specific activity 
200 Ci mM  -1, was added to the dishes for 1 h. The cells were rinsed rap- 
idly five times and then a further five times at 3-rain intervals with Eagle's 
minimum essential medium (Gibco) containing 1% BSA (Sigma Chemical 
Co.).  The  cells  were  trypsinized with 0.7  ml of 0.04%  trypsin (Difco 
Laboratories Inc., Detroit, Mr) in calcium and magnesium  free Earle's salts 
and the reaction stopped with 1.4 ml of Earle's salts containing 1% BSA. 
The harvested cells were counted in a gamma  counter (model NE 1600; Nu- 
clear Enterprises Limited). 
Results 
The freshly isolated cells were seeded at a density of 1.4  × 
llY/35-mm dish and exposed to a complete medium change 
24 h after plating. Under these conditions, 90%  of all cell 
fusion occurred between 48 and 68 h, with 70-75 % of the 
total population undergoing fusion. The cells were routinely 
fixed in midfusion (58 h), when 40-50% of cells in control 
cultures had fused (Table I). 
3  × 10  -6 M Indomethacin and Chloroquine 
Inhibit Myoblast Fusion but Not Other Aspects 
of  Differentiation 
Before using prostanoid-synthesis antagonists as inhibitors of 
myoblast fusion, it was necessary to determine appropriate 
dosing  regimes.  To  this  end,  the  inhibitions  of  fusion 
achieved by indomethacin and chloroquine using 24-,  12-, 
and 6-h dosing were compared (Fig. 1). The data reveal that 
if a given total amount of chloroquine is administered fre- 
quently in small doses, the maximum inhibition obtained is 
increased (Fig.  1 a).  In contrast,  the inhibition of fusion 
achieved by indomethacin is independent of the frequency of 
addition (Fig. 1 b). These findings indicate that indometha- 
cin is stable in the muscle ceils' cultures, whereas chloro- 
quine suffers an effective loss of potency. Under our condi- 
tions of culture, the optimal inhibitory doses are a total of 
3  x  10  -6 M  indomethacin or 1  x  10  -6 M  chloroquine ad- 
ministered every 6 h. When either of these dosing regimes 
was used, the onset of fusion was prevented for ,o12 h. Given 
the technical difficulties of dosing routinely every 6 h,  12-h 
dosing regimes of 1 x  10  -6 M indomethacin or 1 ×  10-6  M 
chloroquine were adopted. Table I illustrates both the effec- 
tiveness and consistency of the inhibitions imposed by these 
dosing regimes. 
Throughout the course of the experiments, indomethacin 
and chloroquine were without effect on total cell numbers 
(Fig. 2 a, Table I). The same was true for the total cellular 
DNA levels. For example, there was no significant difference 
(at the 90%  level) in the mean values obtained from four 
separate experiments for 58-h control, indomethacin- and 
chloroquine-treated cultures. Table II illustrates the cellular 
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Figure 1. The effect of the frequency of dosing on the chloroquine and indomethacin inhibitions of myoblast fusion. The drugs were added 
from 24 h in culture at 24-h intervals (o), 12-h intervals (m), and 6-h intervals (A). The dose response of fusion to the total drug added 
over the 34-h period is presented. These results were generated from three separate experiments. Each value represents the mean 5- SD 
obtained from four separate dishes. (a) Chloroquine-treated cultures. (b) Indomethacin-treated cultures. 
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Figure 2. The time course of cell proliferation,  alignment,  and cell fusion under control conditions,  and in the presence of indomethacin 
and chloroquine. Controls (e); plus 1 x  10  -4 M indomethacin added every 12 h from 24 h in culture (-); plus 1 x  10-6 M chloroqulne 
added every 12 h from 24 h in culture (.); plus both indomethacin (1  x  10  -6 M) and chloroquine (1  x  10  -4 M) added every 12 h from 
24 h in culture (v). All values  represent  the mean of four dishes  +  the SD. (a) Proliferation.  Analysis of the control and drug-treated 
cultures  revealed that the cell numbers were not significantly different at the 95 % level at either 48 or 60 h. (Bartlett's test and analysis of 
variance).  (b) Cell alignment.  The small number of nuclei present in myotubes by 48 h were included  in the aligned  counts,  allowing a 
consistency to be maintained  between the proportion of cells that had undergone alignment  in control and drug-treated cultures.  The 48-h 
data from the control and drug-treated cultures  were not significantly  different at the 95 % level (Bartlett's test and analysis  of variance). 
(c) Cell fusion.  The 58-h data from the control and drug-treated cultures were significantly  different  at >99% level (Bartlett's  test,  no 
significant  difference;  analysis  of variance and Scheffe's multiple  comparisons: all >99%). 
DNA levels obtained from a typical individual experiment. 
As a further and more sensitive assessment of the myoblast 
cell cycle, the incorporation of [3H]thymidine into cellular 
DNA was examined. Again no difference was observed be- 
tween control and treated cultures (Table II). The absence of 
any  effect of either  3  x  10  -6 M  indomethacin  or chloro- 
quine  on  three  separate  parameters  of cell  proliferation 
demonstrates that myoblast proliferation is unaltered by ei- 
ther drug. 
To fuse, myoblasts must first align (25).  It was therefore 
necessary to establish whether or not the drug regimes to be 
used had any effect on the alignment process. The numbers 
of aligned cells were compared in control and treated cul- 
tures by counting the total  number of nuclei  and those in 
aligned or fused cells.  The mean values derived from three 
experiments  for the  proportion  of nuclei  in  aligned/fused 
cells  were  not  significantly  different  between  control  and 
treated cultures at the 90% level. The results of one such typ- 
ical experiment are given in Fig. 2 b. The results demonstrate 
that from 24 to 48 h  neither drug observably hinders  cell 
Table II.  Effects  of Chloroquine  and Indomethacin  on Myoblast Cellular  Function  and Differentiation 
Controls  Controls  Chloroquine  Indomethacin 
Treatment  24 h  58 h  58 h  58 h 
% Fusion  None detected  47.9  +  2.2  14.4  5- 2.6  20.3  5-  3.0 
DNA (ng/cm  2 of dish)  74  5- 7  209  5-  18  195  +  21  209  5-  11 
Cell Nos./cm  2 of dish (x  10  -3)  14.6  5- 2.7  48.9  5-  8.6  52.6  5- 7.1  56.3  5-  3.3 
[3H]Thymidine  incorporation 
(dprrdh)  Not determined  2,078  5-  76  2,178  5-  118  1,887  5-  188 
CPK (nmol/min per ng DNA)  8.3  5- 2.0  29.0  5-  3.3  24.6  +  3.4  29.8  5-  1.9 
% M-CPK-positive staining  8.4  +  1.5  59.5  5- 2.5  58.2  +  4.3  57.7  +  3.8 
Bungarotoxin-binding 
(dpm/ng DNA)  920  +  120  2,000  +  160  2,350  5- 230  2,310  5-  100 
[3H]Leucine  incorporation 
(dpm/h)  Not determined  719  +  149  795  -t- 82  750  +  12 
All values represent the mean 5: the SD of four dishes. CPK, creatine phosphokinase. 
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dishes contain more aligned cells and fewer fused cells than 
their untreated counterparts, the two sets of cultures were in 
fact morphologically indistinguishable. Neither drug caused 
an increase in intracellular vacuolation. These findings indi- 
cate that at 3  x  10  -6 M indomethacin and chloroquine have 
no discernable effects on gross cell morphology. 
To determine the nature of the inhibition of differentiation 
imposed by 3  x  10  -6 M indomethacin and chloroquine, the 
expression of two  muscle-specific proteins  (i.e.,  creatine 
phosphokinase and acetylcholine receptor) was examined. 
Table II demonstrates that neither inhibitor of prostanoid 
synthesis prevents the initial increase in total creatine phos- 
phokinase,  seen in differentiating myogenic cultures.  The 
mean activities of creatine phosphokinase (at 58 h  of cul- 
ture),  derived from three separate experiments,  were not 
significantly different at the 90% level in control and treated 
cultures.  The increase in  creatine phosphokinase activity 
associated  with  myoblast  differentiation  reflects  both  an 
increase  in  accumulation  of  the  nonspecific  isozyme 
(B-creatine phosphokinase) and the de novo expression of 
the  muscle-specific  form  i.e.,  M-creatine  phosphokinase 
(33). No significant difference in the proportion of nuclei in 
cells expressing M-creatine phosphokinase was obtained be- 
tween control and drug-treated cultures (Table II). Similarly, 
indomethacin and chloroquine do not prevent the expression 
of a second parameter of differentiation examined, namely 
the increase in the number of acetylcholine receptors on the 
muscle  cells'  surface.  The  [~5I]~tbungarotoxin  binding  to 
control and drug-treated 58-h cells (in two separate experi- 
ments) was not significantly different at the 90% level. The 
results obtained from one of these experiments are presented 
in Table II. Finally, the drugs have no effect on total protein 
synthesis, since there is no significant difference (at the 90% 
level) in the [3H]leucine incorporated into acid precipitable 
material of  control and drug treated cultures (Table II). From 
these various studies we conclude that both indomethacin 
and chloroquine specifically inhibit myoblast fusion without 
affecting other parameters of muscle differentiation. 
These specific inhibitions of fusion obtained with  3  × 
10  -6 M  indomethacin and chloroquine administered every 
12 h are not complete (Fig. 2 c), and after '~58 h of culture 
they rapidly disappear (data not presented). An additional 
tenfold excess of the drugs  (i.e.,  10  -5 M) administered at 
56 h does not maintain the block. The degree of inhibition 
observed is increased by administering indomethacin and 
chloroquine together; however, these improved inhibitions 
are also rapidly lost after 58 h of culture (data not presented). 
These results strongly suggest that the loss of inhibition is 
not due to a decrease in potency of the drugs. 
Reversal of  the Indomethacin- and Chloroquine- 
imposed Inhibitions of  CeU Fusion Is Rapid, Complete, 
and Specific to PGEI 
The previously reported blocks of fusion imposed by indo- 
methacin or aspirin were reversed 5-6 h after exposure to 
PGE1 (11, 44). In contrast, reversal of the inhibitions of fu- 
sion achieved upon returning low external calcium to control 
levels can be more rapid, occurring after ~1.5 h (31). The 
specific nature of the inhibitions of myoblast fusion imposed 
by chloroquine and indomethacin suggest that like the cal- 
cium reversals,  the reversal by PGE~  should be rapid.  A 
1.5-h exposure to PGE1 (0.32-1.0  x  10  -9 M) was sufficient 
to achieve control levels of fusion in cultures treated with ei- 
ther indomethacin or chloroquine (Fig. 3). A closer exami- 
nation of the kinetics of the PGE~ reversals revealed that 1 
x  10  -9 M  PGEI has no effect on the gross morphology of 
the aligned cells for the first 8 min after its addition. Between 
8 min and 1 h, difficulty is experienced in assessing the state 
of many of the closely opposed nuclei under the light micro- 
scope. After 1 h of exposure the morphological changes are 
sufficiently distinct to assess fusion once more. The fusion 
levels in these 1-h cultures are similar to that of controls (data 
1.2 ° 
X 
1.0. 
Z 
2  ~ 0.8~ 
0.6 
0.4 
0.2. 
0-0 _ 
1.2  m 
)C 
~ I.o 
_z 
Z 
2 
~0-8. 
Ilu 
0.6 
~  0-4 
0.2 
0,0 
---r-J.,,  ,Io-,o  '  ,'o-.  '  -'-r--i.iL  ,Io-,o  '  ,'o-.  '  ,'o-. 
CONCENTRATION  OF POE (Molar)  CONCENTRATION  OF POE (Molar) 
Figure 3. Fusion achieved in indomethacin- and chloroquine-treated cultures exposed to PGE~ 10 or 1.5 h before fixation. PGE: addition 
10 h before fixation (o); PGEt addition 1.5 h before fixation (e). These results were generated from four separate experiments; each value 
represents the mean  +  SD obtained from four separate dishes. (a) Indomethacin-treated cultures. (b) Chloroquine-treated cultures. 
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fusion is rapid.  Exposure of the inhibited culture to PGE~ 
for the longer period of 10 h produced the same pattern of 
reversal (Figs. 4 and 5). 
PGE~  is  the only prostanoid whose effects upon fusion 
have been previously examined. To determine the optimal 
dose for the reversal of the drug-based inhibitions of fusion 
and  the  specificity of this  prostaglandin  action,  dose re- 
sponses  for the  reversals  by  PGE~  and  its  close  relative 
PGE2 were carried out. The prostaglandins were added to 
the  fusion inhibited cultures at 48  h  and  fusion assessed 
10 h later at 58 h.  Fig.  4  demonstrates that PGE~ but not 
PGE2 reverses the blocks imposed on fusion by the prosta- 
noid synthesis antagonists. No reversal of the block of fusion 
is achieved over a  10-h exposure of the myoblasts to a wide 
range of PGE2 concentrations (10-u-10  -6 M).  The PGEI- 
specific response of the  myoblast is  unexpected since  in 
general PGE~ and PGE2 are equipotent. 
The dose-response curves obtained for the PGEt reversal 
are  bell-shaped.  At  concentrations  of PGE~ higher  than 
those necessary to elicit complete reversals of either of the 
drug-imposed inhibitions of fusion (3.2  x  10  -t° -  1 x  10  -9 
M),  additional  effects  are  observed.  Concentrations  of 
PGE~ in excess of 3.2 x  10  -9 M generate only partial rever- 
sals of the inhibitions imposed by either indomethacin (Figs. 
3 and 4) or chloroquine (Figs. 3 and 5). This result, which 
reveals that higher concentrations of the prostaglandin are 
antagonistic to fusion, is independent of whether the cultures 
are exposed to PGE~ for 1.5 or 10 h. Similar levels of fusion 
(i.e., 70 % of untreated) are also obtained in control cultures 
exposed to concentrations of PGE1  in  excess of 10  -8  M. 
Furthermore, in contrast to its ineffectiveness as a reversing 
agent of the inhibited cultures, PGE2 at  10  -8 M  and above 
similarly depresses control fusion (Fig. 5). In their depres- 
sion of control fusion the two prostaglandins are therefore 
equipotent.  The  similarity  between  the  levels  of fusion 
achieved by concentrations in excess of 10  -8 M of PGEt and 
PGE2 in control cultures and of PGE1 in the fusion-blocked 
cultures suggests that these actions have a common underly- 
ing mechanism. The two opposing effects of PGE~, stimula- 
tory and inhibitory, are presumably responsible for the bell 
shape of the fusion dose response curve achieved when the 
prostaglandin is added to cultures previously treated with ei- 
ther indomethacin or chloroquine (Figs.  3-5). 
Effects of  Prostanoid Precursors on Fusion in 
Indomethacin- and Chloroquine-treated Cultures 
To further investigate the specificity of the prostanoid rever- 
sal of the inhibitions of cell fusion, the effects of the prosta- 
noid precursor fatty acids eicosatrienoate, arachidonate, and 
linoleate were assessed.  Eicosatrienoate and arachidonate 
are direct precursors for prostanoids of the one and two se- 
ties,  respectively. Linoleate is an indirect precursor of the 
one  series  prostanoids  since  eicosatrienoate is  generated 
from this fatty acid as a consequence of A-6 dehydrogenase 
activity (32). Both eicosatrienoate and linoleate give com- 
plete reversals of the inhibitions of fusion imposed by either 
indomethacin (Fig. 6) or chloroquine (Fig. 7). Arachidon- 
ate, the precursor to the two series, fails to reverse the drug- 
based  inhibitions  over  a  wide  range  of  concentrations 
(10-tl-10  -6 M). Because all three fatty acid esters should be 
converted to prostanoids, this result suggests that reversal of 
the inhibitions is only achieved when prostanoids of the one 
series are generated. The dose-response curves for reversal 
of the chloroquine-imposed block by eicosatrienoate, linole- 
ate,  and PGE~ are very similar.  In all cases a  bell-shaped 
curve is generated with complete reversal at  10  -9 M,  and 
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Figure 4. Fusion achieved in control and indomethacin-treated cul- 
tures exposed to different concentrations of PGE~ or PGF_~. Con- 
trol plus PGE2 (o); 1 x  10  -6 M indomethacin (dosed every 12 h 
from 24 h in culture) plus (A) PGEt;  1 x  10  -+ M indomethacin 
plus PGE2 (u). The results were generated from two separate ex- 
periments; each value represents the mean  +  SD obtained from 
four separate dishes. 
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Figure 5.  Fusion achieved in control and chloroquine-treated cul- 
tures exposed to different concentration of PGEt or PGE2. Control 
plus PGE]  (e);  1  x  10  -6 M  chloroquine (dosed every 12 h  from 
24 h in culture) plus PGE]  (A);  1  x  10  -6 M  chloroquine plus (m) 
PGE2. The results were generated from two separate experiments; 
each value represents the mean +  SD obtained from four separate 
dishes. 
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Figure 6. Fusion achieved in indomethacin-treated cultures exposed 
to different concentrations of the precursor essential fatty acid es- 
ters of PGEt and PGF_.2. 1  x  10  ~  M  indomethacin  dosed every 
12 h from 24 h in culture; plus eicosatrienoate  (A); plus linoleate 
(e);  plus  arachidonate  (i).  These results  were  generated  from 
three separate experiments; each value represents the mean +  SD 
obtained  from four separate  dishes.  E.EE.,  essential  fatty acid 
ester. 
i 
l,0 
~ 0.8. 
0.6- 
0.4. 
0.2 
0.0 
llO - 11  110-10  110-9  110-8  1[0-7  110-6 
CONCENTRATION  OF  t.F.t.(Molar) 
Figure 7. Fusion achieved in chloroquine-treated cultures exposed 
to different concentrations of the precursor essential fatty acid es- 
ters of PGEt and PGEz. 1 x  10  4  M cMoroquine dosed every 12 h 
from 24 h in culture, plus eicosatrienoate  (*); plus linoleate (e); 
plus  arachidonate  (I).  These results  were generated  from three 
separate experiments;  each value represents  the mean +  SD ob- 
tained from four separate dishes. E.EE., essential fatty acid ester. 
1.O 
lesser degrees of reversal at higher concentrations. The indo- 
methacin block of cell fusion is also reversed by both linole-  z 
ate  and  eicosatrienoate  and  bell-shaped  curves  are  again  z 04. 
generated. In this case the doses required for maximal and  [ 
partial reversals are both 10-fold higher than those effective  -~ 
for the reversal of the chloroquine-treated cultures.  0.6. 
Reversal of the chloroquine and indomethacin inhibitions 
by linoleate and eicosatrienoate has an important implication 
when considering experimental reproducibility. If the levels  0.4. 
of these essential fatty acids in the culture medium are high, 
they will clearly reduce the effectiveness of prostanoid syn- 
thesis inhibitors. That this is a factor in determining the inhi-  o.2. 
bitions  obtained  is  suggested  by our observation that  the 
batch of serum employed markedly affects the degree of inhi- 
bition  achieved  by  both  indomethacin  and  chloroquine,  o.o. 
Similar variability with serum batch has been observed in the 
inhibition of rabbit platelet aggregation by the chloroquine 
analogue mepacrine (2). 
These results  demonstrate that the  inhibitions  of fusion 
generated  by  either  indomethacin  or  chloroquine  can  be 
overcome by the appropriate precursor fatty acids. Chloro- 
quine most probably acts by reducing the availability of free 
fatty acid, whereas indomethacin prevents the conversion of 
the fatty acid to prostanoids. Given their different sites of ac- 
tion, it can be predicted that indomethacin and chloroquine 
will  act synergistically.  Such  a  synergism is  indeed  seen. 
When  indomethacin and chloroquine are administered to- 
gether, an increased inhibition of 86 % is obtained (Fig.  8). 
This inhibition achieved with indomethacin and chloroquine 
combined (3  x  10  -6 M) is completely reversed by 10  -9 M 
PGEI (data not presented). 
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Figure 8.  The dose response  of fusion to the total indomethacin 
added with different levels of chloroquine present. Both indometha- 
cin and chloroquine were added every 12 h from 24 h in culture. 
Indomethacin  alone (I); indomethacin  plus  1 x  10  -7 M chloro- 
quine (e); indomethacin plus  1 x  10  -~ M chloroquine  (A). The 
results were generated in a single experiment; each value represents 
the mean  +  SD obtained from four separate dishes. 
PGEI Cyclic AMP and Cell Fusion 
PGE1  raises intracellular cyclic AMP in avian muscle cell 
cultures (11, 29). However, at concentrations that completely 
reverse the inhibitions of fusion imposed by 3  x  10  -6 M in- 
domethacin or chloroquine, PGEI has no effect on the intra- 
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and Isoproterenol on Myoblast Fusion and 
Intracellular Cyclic AMP 
Fold increase in 
Treatment  Fusion index  cyclic AMP 
Control  1.00  +  0.05 
PGEI  (10  -9 M)  1.07  5:0.08 
PGEI  (10 -7 M)  0.70  +  0.02 
Isoproterenol (10  5  M)  0.70  +  0.04 
Isoproterenol (10  -s M) plus 
propranalol (5  x  10  -5 M)  0.99  +  0.01 
Isoproterenol (10 -8 M)  0.99  +  0.06 
Dibutyryl cyclic AMP 
(1  ×  10  -4 M)  0.67  +  0.06 
1.00  5:0.25 
0.93  5:0.22 
2.52  5:0.27 
2.32  5:0.33 
1.03  5:0.05 
1.47  5:0.20 
Not determined 
Fusion index values represent the mean of four dishes + the SD. Fold increase 
in cyclic AMP values represent the mean of four sets of duplicate values 5: SD. 
cellular cyclic AMP levels (Table III). In agreement with the 
previous studies, cyclic AMP is increased by PGEt, but this 
only occurs when concentrations of the prostaglandin are 
reached that inhibit control myoblast fusion (Table HI). Iso- 
proterenol, a synthetic 13-adrenergic agonist, also raises cy- 
clic AMP in avian myoblast cultures (9). At the concentra- 
tions of isoproterenol that effectively increase cyclic AMP, 
it too inhibits control cell fusion under our conditions (Table 
HI).  The addition of the 13-adrenergic-blocker  propranolol 
2 min before isoproterenol prevents both the depression of 
cell fusion and the increase in intracellular cyclic AMP (Ta- 
ble III). These findings suggest that increases in intracellular 
cyclic AMP of the order of 200-300%  (assayed in the pres- 
ence of isobutylmethylxanthine)  can inhibit myoblast fusion. 
Confirmation of this is provided by the similar depressions 
of control fusion achieved in cultures exposed to dibutyryl 
cyclic AMP (26,  36, Table III). 
Discussion 
lndomethacin and Chloroquine Impose a Specific 
Block upon Myoblast Fusion 
The data presented here demonstrate that indomethacin and 
chloroquine at 3  ×  10  -4 M inhibit myoblast fusion without 
affecting either the expression of acetylcholine receptors or 
the  muscle-specific form of creatine phosphokinase.  The 
results also reveal the lack of effect of either agent on the 
overall level  of protein  synthesis, cell numbers,  and cell 
alignment. Thus, with the dosing regimes employed here, in- 
domethacin and chloroquine act by increasing the ratio of 
bipolar to multinucleate cells without any other discernable 
effects on the morphology, proliferation, or differentiation of 
the myogenic cells. 
In addition to their high degree of specificity with respect 
to myoblast fusion, the inhibitors exhibit further properties 
that make them very useful tools in the examination of the 
mechanisms involved in myoblast fusion. First, the inhibi- 
tions of fusion imposed by either drug are completely and 
rapidly reversible. Second, providing that the inhibitions of 
fusion imposed by indomethacin and chloroquine are studied 
at times corresponding to the early stage of fusion in the con- 
trois, they are both consistent and reproducible. 
Myoblasts that have been prevented from fusing by either 
indomethacin or chloroquine are induced to fuse by PGE~. 
The simplest explanation for this observation is that indo- 
methacin and chloroquine interfere with either the synthesis 
or action of fusion-triggering factors. Indomethacin is best 
known as an inhibitor of cyclooxygenase (16, 38) and conse- 
quently prostanoid synthesis. Other reported effects of the 
drug, with one exception, are seen only at concentrations 
significantly higher than those employed in the present study 
(16, 36).  The exception to this is the inhibition of cyclic 
AMP-dependent protein  kinase by  10  -7  M  indomethacin 
(21). Since we find that increased cyclic AMP is inhibitory 
to  fusion,  it  is  unlikely  that  blockage  of  cyclic  AMP- 
dependent protein kinase accounts for the observed inhibi- 
tions of fusion. 
Chloroquine  inhibits  prostanoid  synthesis  by  blocking 
phospholipases (20, 28, 29, 35), the major enzymes respon- 
sible for the de-esterification and release of  the essential fatty 
acids from which the prostanoids are synthesized (17, 19). It 
has also been demonstrated to inhibit cell replication, protein 
synthesis, and lysosomal function (6,  7,  13). In this study 
chloroquine has no effect on DNA synthesis, cell numbers, 
or protein synthesis. It is therefore unlikely that either of the 
first two alternatives represents its critical action with respect 
to cell fusion. At higher concentrations of chloroquine than 
those used in the present study, the drug inhibits M-creatine 
phosphokinase synthesis, in common with other lysosomo- 
tropic agents (22).  At such concentrations it also causes ex- 
tensive intracellular vacuolation (unpublished observation) 
which is a  general characteristic of lysosomotropic action 
(15). These effects on creatine phosphokinase and intraceUu- 
lar vacuolation were not observed at the lower concentra- 
tions of chloroquine used to specifically block fusion, mak- 
ing  it  unlikely  that  extensive  interference  of  lysosomal 
function is occurring. Additionally, interference with lyso- 
somal function may also reflect chloroquine's inhibition of 
phospholipases (35). We therefore conclude that in this study 
the effects of indomethacin and chloroquine are wholly con- 
sistent  with  their  interfering  with  the  action  of  an  en- 
dogenously produced fusion-regulating prostanoid. 
A Prostanoid of  the One Series Is Involved in the 
Regulation of  Myoblast Fusion 
Cyclooxygenase does not select between its two substrates, 
and both arachidonate and eicosatrienoate are rapidly con- 
verted to the corresponding prostaglandins (42).  The inabil- 
ity of arachidonate to reverse the fusion block therefore im- 
plies that it is only prostanoids belonging to the one series 
which can trigger fusion. It is unlikely that eicosatrienoate 
and  linoleate  act  directly  to  trigger  fusion,  since  these 
precursor fatty acids would then mimic PGE~. PGE1 gener- 
ates the same dose responses for the reversal of both indo- 
methacin and  chloroquine;  this  is  not  the  case  with  ei- 
cosatrienoate or linoleate (Figs. 4 and 5 compared with Figs. 
6 and 7). The finding that a prostanoid of the one series is 
a specific effector of myoblast fusion is unexpected and has 
a number of implications. First, although in many of their 
actions  PGEI  and  PGE2  are  equipotent,  the  PGE~-  and 
eicosatrienoate-specific effects reported here imply that the 
myoblast possesses a receptor with restricted sensitivity to 
prostaglandins of the one series.  Second, cell membranes 
rarely contain significant quantities of esterified eieosatrie- 
noate (32).  This is also true of the myoblast (3, 23).  This 
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possibility is linoleate. Myoblast membranes contain large 
quantities of this fatty acid in esterified form. Furthermore, 
in many tissues and cell types, it has been demonstrated that 
eicosatrienoate can be generated from linoleate by the action 
of A-6 dehydrogenase (32). That this is the case in the myo- 
blast is suggested by the ability of linoleic acid to stimulate 
control fusion (34) and to be as effective as eicosatrienoate 
in overcoming the inhibitions imposed upon fusion by indo- 
methacin and chloroquine. We conclude therefore that the 
lack of esterified eicosatrienoate does not preclude the in- 
volvement of a  series-one prostanoid in the regulation of 
myoblast fusion. 
Finally,  the  transient  nature  of the  indomethacin and 
chioroquine-based inhibitions of fusion must be considered. 
Adding higher concentrations of these drugs (1  x  10  -5 M) 
before the loss of  inhibition of  fusion at ,,058 h of culture does 
not prolong the block imposed by either of the drugs. This 
suggests that the loss of these inhibitions is not due to a loss 
in efficacy of the inhibitors of prostanoid synthesis. It further 
implies that during fusion, a prostanoid-independent mecha- 
nism is operating to initiate fusion. That this is so is indicated 
by the  finding that fusion is  also  controlled through the 
acetylcholine receptors  (1) utilizing an as yet unidentified 
agonist. From these findings we conclude prostanoids are not 
the only regulators of myoblast fusion. 
Cyclic AMP  Does Not Mediate the Prostanoid 
Regulation of  Fusion 
It seems very unlikely that cyclic AMP is the mediator of 
PGEt-induced fusion. At the concentrations of the prosta- 
glandin that completely reverse the drug-imposed inhibitions 
of cell fusion, PGE~ does not significantly raise intracellu- 
lar cyclic AMP. Additionally, at the higher concentrations of 
PGE~ capable of increasing the level of the cyclic nucleo- 
tide, control fusion is depressed and only partial reversals of 
the block imposed by the inhibitors of prostanoid synthesis 
are achieved. From these observations, plus the ineffective- 
ness of the 13-adrenergic agonist isoproterenol to reverse the 
fusion block, we conclude that PGE~ does not trigger fusion 
by activation of adenylate cyclase. The results in fact indicate 
that increases in cyclic AMP are antagonistic to the fusion 
event. 
The apparent contradiction between the cyclic AMP de- 
pression of fusion seen here and previous reports of stimula- 
tions of cell fusion by the cyclic nucleotide is reconcilable. 
The stimulations of myoblast fusion by cyclic AMP occur 
when the synthesis of the cyclic nucleotide is induced ,,o10 h 
before the predicted time of the onset of fusion in controls 
(9, 44). The depression of fusion reported here is the conse- 
quence of exposing myoblasts that are undergoing active fu- 
sion to an increase in cyclic AMP. There is also a difference 
in the time it takes the cell to respond in the two situations. 
A minimum lag of 4-5 h is seen before an elevation of cyclic 
AMP induces precocious fusion, whereas the inhibitions of 
fusion are imposed by the cyclic nucleotide within 1.5 h. 
Taken together, these findings have two implications. First, 
that the depression of fusion by cyclic AMP is a separate ac- 
tion from the cyclic-nucleotide-mediated stimulation of cell 
fusion. Second, that the depressions of fusion imposed by 
cyclic AMP are due to the cyclic nucleotide's antagonism of 
a process that is occurring close to the fusion event itself. 
The obvious alternative as intracellular mediator of pros- 
tanoid triggered cell fusion is calcium. The dependence of 
myoblast recognition-alignment on extracellular calcium is 
well documented (25). In addition, there is evidence that cal- 
cium is required forthe fusion event itself. For example, the 
calcium ionophore A23187 induces precocious fusion in con- 
trol cultures (11, 12), whereas the calcium blockers D600 and 
lanthanum prevent its onset (11, 14). In a preliminary study 
to explore the possible connection between extracellular cal- 
cium and PGE~ action, we have found that both D600 and 
lanthanum prevent the prostaglandin reversal of the fusion 
block imposed by inhibitors of prostanoid synthesis (14). 
This result implies that PGE~ triggers fusion by causing an 
influx of calcium, a contention that is supported by the fol- 
lowing findings. First, PGE~ increases the net influx of cal- 
cium into fusing chick myoblasts. Second, the kinetics of the 
fusion achieved after the return of external calcium levels to 
normal levels or the  addition of PGE1 to  fusion-blocked 
cultures are very similar. Taken together, the data strongly 
suggest that myoblast fusion is regulated by a  series-one 
prostanoid that triggers an influx of calcium. Work is now 
in progress to elucidate the mechanism of calcium entry. 
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